Hydroxychloroquine: A diabetic drug in disguise?

Lydia Kang; Ted R. Mikuls; James R. O'Dell

doi:10.1136/bcr.08.2008.0654

Hydroxychloroquine: A diabetic drug in disguise?

Lydia Kang, Ted R. Mikuls, James R. O'Dell

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Abstract

Hydroxychloroquine (HCQ) is an antimalarial agent that is commonly used to treat rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). The present report documents a case of hypoglycaemia due to HCQ in a patient with SLE and diabetes mellitus type 2, in which the HCQ completely replaced the need for daily subcutaneous insulin.

Original language	English (US)
Journal	BMJ case reports
DOIs	https://doi.org/10.1136/bcr.08.2008.0654
State	Published - Mar 2 2009

ASJC Scopus subject areas

General Medicine

Access to Document

10.1136/bcr.08.2008.0654

Cite this

@article{02ac18b6b2ea411fbbbb4697765bb753,

title = "Hydroxychloroquine: A diabetic drug in disguise?",

abstract = "Hydroxychloroquine (HCQ) is an antimalarial agent that is commonly used to treat rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). The present report documents a case of hypoglycaemia due to HCQ in a patient with SLE and diabetes mellitus type 2, in which the HCQ completely replaced the need for daily subcutaneous insulin.",

author = "Lydia Kang and Mikuls, {Ted R.} and O'Dell, {James R.}",

year = "2009",

month = mar,

day = "2",

doi = "10.1136/bcr.08.2008.0654",

language = "English (US)",

journal = "BMJ case reports",

issn = "1757-790X",

publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - Hydroxychloroquine

T2 - A diabetic drug in disguise?

AU - Kang, Lydia

AU - Mikuls, Ted R.

AU - O'Dell, James R.

PY - 2009/3/2

Y1 - 2009/3/2

N2 - Hydroxychloroquine (HCQ) is an antimalarial agent that is commonly used to treat rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). The present report documents a case of hypoglycaemia due to HCQ in a patient with SLE and diabetes mellitus type 2, in which the HCQ completely replaced the need for daily subcutaneous insulin.

AB - Hydroxychloroquine (HCQ) is an antimalarial agent that is commonly used to treat rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). The present report documents a case of hypoglycaemia due to HCQ in a patient with SLE and diabetes mellitus type 2, in which the HCQ completely replaced the need for daily subcutaneous insulin.

UR - http://www.scopus.com/inward/record.url?scp=84886095389&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886095389&partnerID=8YFLogxK

U2 - 10.1136/bcr.08.2008.0654

DO - 10.1136/bcr.08.2008.0654

M3 - Article

C2 - 21686697

AN - SCOPUS:84886095389

SN - 1757-790X

JO - BMJ case reports

JF - BMJ case reports

ER -

Hydroxychloroquine: A diabetic drug in disguise?

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this